133 related articles for article (PubMed ID: 29983570)
21. Erratum: Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum].
Clinicoecon Outcomes Res; 2016; 8():305. PubMed ID: 27445500
[TBL] [Abstract][Full Text] [Related]
22. Erratum: Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum].
Clinicoecon Outcomes Res; 2018; 10():731. PubMed ID: 30510435
[TBL] [Abstract][Full Text] [Related]
23. Erratum: A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum.
Clin Pharmacol; 2018; 10():71. PubMed ID: 29928148
[TBL] [Abstract][Full Text] [Related]
24. The NOVEL trial: natural orifice versus laparoscopic cholecystectomy-a prospective, randomized evaluation.
Schwaitzberg SD; Roberts K; Romanelli JR; Desilets DJ; Earle D; Horgan S; Swanstrom L; Hungness E; Soper N; Kochman ML;
Surg Endosc; 2018 May; 32(5):2505-2516. PubMed ID: 29218667
[TBL] [Abstract][Full Text] [Related]
25. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
26. Erratum: Utility of the Morisky Medication Adherence Scale in gout: a prospective study [Corrigendum].
Patient Prefer Adherence; 2018; 12():527. PubMed ID: 29686486
[TBL] [Abstract][Full Text] [Related]
27. Erratum: Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum].
Clinicoecon Outcomes Res; 2018; 10():155. PubMed ID: 29559803
[TBL] [Abstract][Full Text] [Related]
28. Erratum: Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum].
Drug Healthc Patient Saf; 2018; 10():67-68. PubMed ID: 30038524
[TBL] [Abstract][Full Text] [Related]
29. Erratum: Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum].
Cancer Manag Res; 2018; 10():613. PubMed ID: 29630065
[TBL] [Abstract][Full Text] [Related]
30. Erratum: Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum].
Neuropsychiatr Dis Treat; 2015; 11():863. PubMed ID: 25848284
[TBL] [Abstract][Full Text] [Related]
31. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
32. Erratum: Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum].
Neuropsychiatr Dis Treat; 2019; 15():655. PubMed ID: 30880990
[TBL] [Abstract][Full Text] [Related]
33. Erratum: Effectiveness of the "Elderly Activity Performance Intervention" on elderly patients' discharge from a short-stay unit at the emergency department: a quasi-experimental trial [Corrigendum].
Clin Interv Aging; 2018; 13():1647. PubMed ID: 30237700
[TBL] [Abstract][Full Text] [Related]
34. Erratum: Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():945. PubMed ID: 28360518
[TBL] [Abstract][Full Text] [Related]
35. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
[TBL] [Abstract][Full Text] [Related]
36. Erratum: User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study [Corrigendum].
Patient Prefer Adherence; 2013; 7():803. PubMed ID: 23983458
[TBL] [Abstract][Full Text] [Related]
37. Erratum: Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections [Corrigendum].
Infect Drug Resist; 2019; 12():431. PubMed ID: 30863125
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum].
Clin Ophthalmol; 2017; 11():355. PubMed ID: 28243059
[TBL] [Abstract][Full Text] [Related]
39. Erratum: Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():245. PubMed ID: 30718950
[TBL] [Abstract][Full Text] [Related]
40. Erratum: Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum].
Clinicoecon Outcomes Res; 2017; 9():231. PubMed ID: 28458569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
